+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Primary Biliary Cholangitis Drug"

Primary Biliary Cholangitis Therapeutics Market By Drug type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market By Drug type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • June 2023
  • 229 Pages
  • Global
From
Primary Biliary Cholangitis - Pipeline Insight, 2023 - Product Thumbnail Image

Primary Biliary Cholangitis - Pipeline Insight, 2023

  • Clinical Trials
  • November 2023
  • 80 Pages
  • Global
From
Global Primary Biliary Cholangitis Therapeutics Market 2024-2028 - Product Thumbnail Image

Global Primary Biliary Cholangitis Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 151 Pages
  • Global
From
Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 195 Pages
  • Global
From
Primary Biliary Cholangitis (PBC) Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Primary Biliary Cholangitis (PBC) Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 110 Pages
  • Global
From
Primary Biliary Cholangitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Primary Biliary Cholangitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2022
  • 66 Pages
  • Global
From
Primary Biliary Cholangitis Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials - Product Thumbnail Image

Primary Biliary Cholangitis Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • Report
  • November 2021
  • 70 Pages
  • Global
From
Primary Biliary Cholangitis (Cirrhosis) Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook - Product Thumbnail Image

Primary Biliary Cholangitis (Cirrhosis) Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook

  • Report
  • July 2020
  • 102 Pages
  • Global
From
Primary Biliary Cholangitis (PBC) Therapeutics Market Growth Analysis and Insights, 2021: Trends, Market Size, Share Outlook and Opportunities by Type, Application, End Users, Countries and Companies to 2028 - Product Thumbnail Image

Primary Biliary Cholangitis (PBC) Therapeutics Market Growth Analysis and Insights, 2021: Trends, Market Size, Share Outlook and Opportunities by Type, Application, End Users, Countries and Companies to 2028

  • Report
  • September 2021
  • 135 Pages
  • Global
From
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 149 Pages
  • Global
From
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Pipeline Report, 2023 - Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies - Product Thumbnail Image

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Pipeline Report, 2023 - Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

  • Report
  • February 2023
  • 150 Pages
  • Global
From
Primary Biliary Cholangitis (PBC) Therapeutics Market Size Outlook to 2028 - Growth Opportunities, Primary Biliary Cholangitis (PBC) Therapeutics Market Insights, Companies, Market share by Types, Applications, and Countries - Product Thumbnail Image

Primary Biliary Cholangitis (PBC) Therapeutics Market Size Outlook to 2028 - Growth Opportunities, Primary Biliary Cholangitis (PBC) Therapeutics Market Insights, Companies, Market share by Types, Applications, and Countries

  • Report
  • May 2022
  • 148 Pages
  • Global
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Primary Biliary Cholangitis (PBC) is a chronic liver disease caused by the destruction of the bile ducts in the liver. It is a type of autoimmune disorder, in which the body's immune system mistakenly attacks healthy cells and tissues. Treatment for PBC includes medications to reduce inflammation, slow the progression of the disease, and improve liver function. The PBC drug market is a subset of the larger liver and kidney disorders drugs market. It includes medications that are used to treat PBC, such as ursodeoxycholic acid (UDCA), obeticholic acid (OCA), and elafibranor. These drugs are used to reduce inflammation, slow the progression of the disease, and improve liver function. In addition, there are other drugs used to treat the symptoms of PBC, such as antidiarrheal medications, antispasmodics, and antacids. The companies in the PBC drug market include AbbVie, Allergan, Gilead Sciences, Intercept Pharmaceuticals, Merck, and Novartis. Show Less Read more